Rogue breast tumor proteins point to potential drug therapies

For patients with difficult-to-treat cancers, doctors increasingly rely on genomic testing of tumors to identify errors in the DNA that indicate a tumor can be targeted by existing therapies. But this approach overlooks rogue proteins that may be driving cancer cells and also could be targeted with existing treatments, according to research.

from Top Health News – ScienceDaily http://ift.tt/2nwnzn6
from Tumblr http://ift.tt/2nwlesq